Reversal of Systemic Anticoagulants and Antiplatelet Therapeutics
David Dornbos1, Shahid M Nimjee1
1Department of Neurological Surgery, Ohio State University Medical Center, N-1014 Doan Hall, 410 West 10th Avenue, Columbus, OH, USA.
Insights
Managing antiplatelet and anticoagulant medications is crucial for neurosurgical patients facing bleeding risks or needing urgent procedures. This review details current therapies and emergency reversal strategies for these antithrombotic agents.
Area of Science:
- Neurosurgery
- Cardiology
- Hematology
Background:
- Antiplatelet and anticoagulant medications are vital for cardiac conditions, stroke prevention, and venous thromboembolic events.
- These medications present a significant challenge in neurosurgical settings, especially with intracranial hemorrhage or before emergency procedures.
Purpose of the Study:
- To provide a comprehensive summary of current antiplatelet and anticoagulant therapies.
- To review the role of emergency reversal strategies for these medications in neurosurgical patients.
Main Methods:
- Literature review of current antiplatelet and anticoagulant therapies.
- Analysis of emergency reversal strategies and their application in neurosurgical procedures.
Main Results:
- Many current antithrombotic therapies lack direct reversal agents.
- Various strategies exist to reverse or mitigate the effects of antiplatelet and anticoagulant drugs.
Conclusions:
- Effective management of antithrombotic agents is critical for neurosurgical patient safety.
- Understanding emergency reversal options is essential for mitigating bleeding risks in neurosurgery.
Abstract:
Although antiplatelet medications and anticoagulants are necessary for numerous cardiac comorbidities, prevention of stroke, and treatment and prevention of venous thromboembolic events, they pose a significant treatment dilemma in neurosurgical patients, particularly in the setting of intracranial hemorrhage or prior to emergent neurosurgical procedures. For the majority of current anticoagulation and antiplatelet therapies, no direct reversal agents exist; however, there are numerous strategies that can be used to reverse or mitigate their antithrombotic properties. This review provides a comprehensive summary of the latest antiplatelet and anticoagulant therapies and the role of emergency reversal prior to emergent neurosurgical procedures.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Therapeutic Index
Second Order systems II
Reversible and Irreversible Processes
Diode: Reverse bias


